By Iain Gilbert
Date: Tuesday 11 Jun 2024
(Sharecast News) - Biotechnology group Novacyt and the UK's Department of Health and Social Care have reached a commercial settlement of all claims and counterclaims in High Court proceedings.
By Josh White
Date: Friday 19 Apr 2024
(Sharecast News) - Molecular diagnostics specialist Novacyt updated the market on legal proceedings between itself and its subsidiary Primer Design against the Department of Health and Social Care (DHSC) on Friday.
By Josh White
Date: Tuesday 06 Feb 2024
(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan.
Currency | UK Pounds |
Share Price | 47.60p |
Change Today | -3.90p |
% Change | -7.57 % |
52 Week High | 80.30 |
52 Week Low | 36.90 |
Volume | 424,483 |
Shares Issued | 70.63m |
Market Cap | £33.62m |
RiskGrade | 453 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:45 | 3,000 @ 46.79p |
10:42 | 5,000 @ 46.79p |
10:39 | 2,338 @ 46.79p |
10:30 | 3,000 @ 47.00p |
10:30 | 4,240 @ 47.03p |
You are here: research